Stock TGRNF TONG REN TANG TECHNOLOGIES CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Tong Ren Tang Technologies Co. Ltd. OTC Markets

Equities

TGRNF

CNE100000585

Pharmaceuticals

Delayed OTC Markets
Other stock markets
 20:49:40 12/06/2024 BST 		5-day change 1st Jan Change
0.6883 USD -20.11% Intraday chart for Tong Ren Tang Technologies Co. Ltd. -20.11% -20.11%
06-12 Tong Ren Tang Technologies Co. Ltd. Announces Board Change CI
04-30 Beijing Tong Ren Tang Gets Nod to Sell Fever Drug in Hong Kong MT

Business Summary

Tong Ren Tang Technologies Co Ltd is a China-based company mainly engaged in the manufacture and sale of traditional Chinese medicine products. The Company's main businesses includes the production, retail and wholesale of traditional Chinese medicine products and health care products and the provision of traditional Chinese medicine diagnosis and treatment services. The Company is also engaged in the production, processing and acquisition of Chinese herbal medicines, drug sales, medical services and advertising. The Company mainly distributes its products in the domestic market and overseas markets.

Number of employees: 4,101

Sales per Business

HKD in Million2022Weight2023Weight Delta
The Company
58.8 %
4,012 57.6 % 4,398 58.8 % +9.62%
Others
20.9 %
1,292 18.5 % 1,563 20.9 % +20.96%
Tong Ren Tang Chinese Medicine
20.4 %
1,664 23.9 % 1,524 20.4 % -8.41%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
81.4 %
5,662 81.3 % 6,092 81.4 % +7.59%
International
18.6 %
1,306 18.7 % 1,393 18.6 % +6.68%

Managers

Managers TitleAgeSince
Jia Fu Chen CEO
 Chief Executive Officer 55 14/06/23
Guan Zhao Han LAW
 General Counsel 45 -
Shu Wu Zhao PRN
 Corporate Officer/Principal 42 -
Yijun Li SEC
 Corporate Secretary 40 03/05/23
Gui Qin Guo PRN
 Corporate Officer/Principal 59 -
Cun Ying Liu PRN
 Corporate Officer/Principal 59 -
Jian Bai PRN
 Corporate Officer/Principal 64 -
Mei Yee Yung SEC
 Corporate Secretary - 03/05/23

Members of the board

Members of the board TitleAgeSince
Ching Har Chan BRD
 Director/Board Member 67 11/06/18
Yuan Jing Zhan BRD
 Director/Board Member 80 11/06/18
Yi Gang Wu BRD
 Director/Board Member 65 21/10/03
Shu Bing Di CHM
 Chairman 49 01-21
Zhi Mei Feng BRD
 Director/Board Member 54 15/12/21
Li Feng BRD
 Director/Board Member 48 21/12/22
Chun Rui Wang BRD
 Director/Board Member 41 15/02/23
Jia Fu Chen CEO
 Chief Executive Officer 55 14/06/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 652,080,000 0 0 45.64 %
Stock B 1 628,704,000 584,575,000 ( 92.98 %) 0

Shareholders

NameEquities%Valuation
HHLR Advisors Ltd.
7.581 %
47,663,000 7.581 % 32 M $
Sai Nan Yuan
5.683 %
35,732,000 5.683 % 24 M $
Beijing Tong Ren Tang Group Co Ltd
1.217 %
7,649,000 1.217 % 5 M $
UBS Asset Management (Hong Kong) Ltd.
0.9162 %
5,760,000 0.9162 % 4 M $
UBS SDIC Fund Management Co., Ltd.
0.1848 %
1,162,000 0.1848 % 791 659 $
Fullgoal Fund Management Co., Ltd.
0.1384 %
870,000 0.1384 % 592 722 $
Dimensional Fund Advisors Ltd.
0.1014 %
637,468 0.1014 % 434 301 $
State Street Global Advisors Ltd.
0.0286 %
179,999 0.0286 % 122 632 $
China Asset Management (Hong Kong) Ltd.
0.0250 %
157,000 0.0250 % 106 963 $
China Universal Asset Management (Hong Kong) Co. Ltd.
0.0159 %
100,000 0.0159 % 68 129 $
NameEquities%Valuation
BEIJING TONGRENTANG CO., LTD
92.01 %
600,000,000 92.01 % 409 M $
Beijing Tong Ren Tang Group Co Ltd
1.454 %
9,480,000 1.454 % 6 M $

Holdings

NameEquities%Valuation
BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED
38.05%
 318,540,000 38.05% 389,657,240 $

Company contact information

Tong Ren Tang Technologies Co., Ltd.

No.20 Nansanhuan Zhonglu Fengtai District

100079, Beijing

+86 10 8763 2888

http://www.tongrentangkj.com
address Tong Ren Tang Technologies Co. Ltd.(TGRNF)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Alternative Medicine

Sales per Business

Sales per region

Ratings for Tong Ren Tang Technologies Co. Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.859 CNY
Average target price
6.058 CNY
Spread / Average Target
+24.67%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+34.37% 5.88B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-27.13% 3.87B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+4.75% 3.28B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-20.80% 2.78B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-10.70% 2.29B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+49.04% 1.98B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+49.16% 1.54B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-16.86% 1.51B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-9.87% 1.48B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 1666 Stock
  4. TGRNF Stock
  5. Company Tong Ren Tang Technologies Co. Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW